News Release
- 2023.6.21
- Yuji Kogami appointed as new CEO
- 2021.5.20
- IAM is announcing a collaboration with the Institute of Physical and Chemical Research (RIKEN) covering multiple therapeutic areas.
- 2021.5.20
- IAM’s CEO, Hiroyuki Kouji, will be presenting a lecture at the 25th meeting of The Japanese Association for Molecular Target Therapy of Cancer (May 26-28)
- 2020.5.7
- Hiroyuki Kouji appointed as new CEO
- 2019.2.5
- IAM wins Grand Prize in “16th Oita Business Plan Grand Prix”